(2020). Favipiravir: Hyperuricaemia and acute gouty arthritis following off-label use: case report. Reactions Weekly.
Chicago-стиль цитирования"Favipiravir: Hyperuricaemia and Acute Gouty Arthritis Following Off-label Use: Case Report." Reactions Weekly 2020.
MLA-цитирование"Favipiravir: Hyperuricaemia and Acute Gouty Arthritis Following Off-label Use: Case Report." Reactions Weekly 2020.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.